valine and simvastatin

valine has been researched along with simvastatin in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's10 (76.92)29.6817
2010's2 (15.38)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Aljada, A; Dandona, P; Garg, R; Ghanim, H; Hofmayer, D; Kumar, V; Mohanty, P; Syed, T; Tripathy, D1
Li, Q; Liu, L; Xiao, J; Xu, Z; Zhao, S1
Li, Z; Liu, J; Luo, CH; Tan, ZR; Wang, A; Wang, LS; Yu, BN; Zhang, W; Zhou, G; Zhou, HH1
Laverty, R; Ledingham, JM1
Humbert, H; Pommier, F; Prasad, P; Reynolds, CV; Sunkara, G; Yeh, C1
Glazer, R; Jia, Y; Kariisa, M; Pitt, B; Prescott, MF; Radauceanu, A; Rajagopalan, S; Zannad, F1
Baker, AB; Beigel, R; Chatzizisis, YS; Coskun, AU; Daley, W; Edelman, ER; Feldman, CL; Gerrity, RG; Jonas, M; Maynard, C; Stone, BV; Stone, PH1
Baranova, E; Ferber, P; Kandra, A; Okopien, B; Rump, LC; Weisskopf, M1
Aoyama, I; Bomsztyk, K; Komers, R; Koopmeiners, JS; Naito, M; Schnaper, HW; Shenoy, A1
Mullangi, R; Ramani, AV; Sengupta, P1
Boulton, DW; Chang, M; Griffen, SC; Kasichayanula, S; LaCreta, FP; Liu, X; Shyu, WC1
Bauer, CA; Grimme, S1
Abufreha, N; Dahari, H; Dizengof, V; Etzion, O; Nevo-Shor, A; Yardeni, D1

Trials

7 trial(s) available for valine and simvastatin

ArticleYear
Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:9

    Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Blotting, Western; C-Reactive Protein; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; I-kappa B Proteins; Isoquinolines; Leukocytes; Male; Monocytes; Neutrophils; NF-kappa B; Quinapril; Reactive Oxygen Species; Simvastatin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan

2003
Simvastatin reduces interleukin-1beta secretion by peripheral blood mononuclear cells in patients with essential hypertension.
    Clinica chimica acta; international journal of clinical chemistry, 2004, Volume: 344, Issue:1-2

    Topics: Aged; Angiotensin II; Cross-Sectional Studies; Drug Therapy, Combination; Female; Humans; Hypertension; Inflammation; Interleukin-1; Leukocytes, Mononuclear; Lipids; Male; Middle Aged; Simvastatin; Tetrazoles; Valine; Valsartan

2004
Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients.
    European journal of clinical pharmacology, 2005, Volume: 60, Issue:12

    Topics: Adult; Aged; Asian People; China; Cholesterol; Cortisone; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Female; Gene Frequency; Humans; Hydrocortisone; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Isoleucine; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Simvastatin; Triglycerides; Valine

2005
Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
    Current medical research and opinion, 2007, Volume: 23, Issue:3

    Topics: Adult; Antihypertensive Agents; Confidence Intervals; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Hypolipidemic Agents; Male; Probability; Reference Values; Risk Factors; Sensitivity and Specificity; Simvastatin; Single-Blind Method; Tetrazoles; Time Factors; Valine; Valsartan

2007
Effects of valsartan alone versus valsartan/simvastatin combination on ambulatory blood pressure, C-reactive protein, lipoproteins, and monocyte chemoattractant protein-1 in patients with hyperlipidemia and hypertension.
    The American journal of cardiology, 2007, Jul-15, Volume: 100, Issue:2

    Topics: Antihypertensive Agents; Biomarkers; Blood Pressure Monitoring, Ambulatory; C-Reactive Protein; Chemokine CCL2; Double-Blind Method; Drug Combinations; Drug Synergism; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Simvastatin; Tetrazoles; Valine; Valsartan

2007
Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
    Clinical therapeutics, 2008, Volume: 30, Issue:10

    Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypertension; Lipoproteins, LDL; Male; Middle Aged; Simvastatin; Tetrazoles; Valine; Valsartan

2008
Lack of pharmacokinetic interactions between dapagliflozin and simvastatin, valsartan, warfarin, or digoxin.
    Advances in therapy, 2012, Volume: 29, Issue:2

    Topics: Adult; Anti-Arrhythmia Agents; Anticholesteremic Agents; Anticoagulants; Antihypertensive Agents; Benzhydryl Compounds; Cross-Over Studies; Diabetes Mellitus, Type 2; Digoxin; Drug Interactions; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Simvastatin; Sodium-Glucose Transporter 2 Inhibitors; Tetrazoles; Valine; Valsartan; Warfarin

2012

Other Studies

6 other study(ies) available for valine and simvastatin

ArticleYear
Effects of glitazones on blood pressure and vascular structure in mesenteric resistance arteries and basilar artery from genetically hypertensive rats.
    Clinical and experimental pharmacology & physiology, 2005, Volume: 32, Issue:11

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Basilar Artery; Blood Pressure; Disease Models, Animal; Drug Therapy, Combination; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Mesenteric Arteries; Pioglitazone; Rats; Rats, Inbred SHR; Rats, Wistar; Rosiglitazone; Simvastatin; Tetrazoles; Thiazolidinediones; Tunica Media; Valine; Valsartan

2005
Attenuation of inflammation and expansive remodeling by Valsartan alone or in combination with Simvastatin in high-risk coronary atherosclerotic plaques.
    Atherosclerosis, 2009, Volume: 203, Issue:2

    Topics: Animals; Antihypertensive Agents; Atherosclerosis; Blood Pressure; Coronary Artery Disease; Disease Models, Animal; Endothelium, Vascular; Inflammation; Lipids; Male; Rabbits; Risk; Simvastatin; Stress, Mechanical; Tetrazoles; Valine; Valsartan

2009
High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin.
    American journal of nephrology, 2009, Volume: 30, Issue:2

    Topics: Angiotensin II; Gene Expression Regulation; Glucose; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Inflammation; Kidney; Mesangial Cells; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Simvastatin; Tetrazoles; Valine; Valsartan

2009
Development and validation of a highly sensitive and robust LC-ESI-MS/MS method for simultaneous quantitation of simvastatin acid, amlodipine and valsartan in human plasma: application to a clinical pharmacokinetic study.
    Biomedical chromatography : BMC, 2009, Volume: 23, Issue:6

    Topics: Acetonitriles; Amlodipine; Antihypertensive Agents; Chromatography, High Pressure Liquid; Humans; Male; Reproducibility of Results; Sensitivity and Specificity; Simvastatin; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Tetrazoles; Time Factors; Valine; Valsartan

2009
First principles calculation of electron ionization mass spectra for selected organic drug molecules.
    Organic & biomolecular chemistry, 2014, Nov-21, Volume: 12, Issue:43

    Topics: Chemistry, Pharmaceutical; Erythromycin; Humans; Lovastatin; Paclitaxel; Prescription Drugs; Simvastatin; Spectrometry, Mass, Electrospray Ionization; Tetrazoles; Valine; Valsartan

2014
Sustained virological response following an 11-day course of direct acting antiviral therapy for hepatitis C infection.
    Journal of gastrointestinal and liver diseases : JGLD, 2020, Jun-04, Volume: 29, Issue:2

    Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Carbamates; Cyclopropanes; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lactams, Macrocyclic; Middle Aged; Proline; Ritonavir; Simvastatin; Sulfonamides; Sustained Virologic Response; Uracil; Valine

2020